This is a double-blind, placebo-controlled, parallel group study designed to assess the
efficacy of full spectrum CBD and broad spectrum CBD, compared to a placebo control (PC), to
reduce drinking in participants with moderate alcohol use disorder according to the DSM-V. If
eligible for the study, subjects will be randomized to receive one of the conditions for 8
weeks.